Ascendis Pharma A Income Statement (2012-2026) | ASND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & Cost
Revenue (Quarter)	0.00B	0.00B	0.10B	0.01B	0.01B	0.02B	0.02B	0.04B	0.05B	0.05B	0.33B	0.10B	0.04B	0.06B	0.33B	0.11B	0.18B	0.25B	0.48B	0.29B
Interest income
Interest Income - Deposits (Quarter)
Interest Income - Total (Quarter)	0.01B	-0.03B	-0.02B	-0.01B	-0.08B	0.01B	-0.01B	-0.05B	-0.04B	0.00B	-0.00B	0.00B	-0.02B	-0.02B	-0.07B	-0.03B	-0.06B	-0.01B	-0.17B	0.01B
Interest expenses
Interest Expense - Deposits (Quarter)	-0.13B	0.37B	-0.29B	0.85B	-0.09B	-0.07B	-0.18B	0.54B	-0.12B	0.05B	-0.05B	0.35B	-0.07B	0.40B	-0.07B	0.54B	-0.03B
Interest Expense - Others (Quarter)			-0.00B				-0.00B								-0.00B
Interest Expenses (Quarter)	0.01B	0.00B	-0.00B	0.01B	0.01B	0.04B	-0.00B	0.01B	0.01B	0.03B	0.01B	0.08B	0.02B	0.03B	-0.00B	-0.05B	0.04B	0.08B	0.07B	0.08B
Interest Income - Net (Quarter)	-0.00B	-0.03B	-0.02B	-0.02B	-0.09B	-0.03B	-0.01B	-0.06B	-0.05B	-0.02B	-0.01B	-0.08B	-0.04B	-0.04B	-0.07B	0.02B	-0.10B	-0.09B	-0.24B	-0.07B
Non-interest income
Investment Gain (Loss) (Quarter)	0.06B	0.05B	0.04B	0.07B	0.08B	0.09B	0.06B	0.23B	0.05B	0.03B	0.01B	0.01B			-0.00B
Income - Equity (Quarter)								0.00B	0.01B	0.01B	0.00B	0.01B	0.01B	0.00B	0.00B	-0.03B	0.00B	0.01B	-0.00B	0.01B
Non-Interest Income (Quarter)	0.06B	0.05B	0.04B	0.07B	0.08B	0.09B	0.06B	0.23B	0.06B	0.03B	0.01B	0.01B	0.01B	0.00B	0.00B	-0.03B	0.00B	0.01B	-0.00B	0.01B
Trading Income (Quarter)
Operating Items
Research & Development (Quarter)	0.10B	0.07B	0.08B	0.09B	0.10B	0.10B	0.11B	0.11B	0.11B	0.12B	0.10B	0.08B	0.09B	-0.08B	-0.08B	-0.09B	0.08B	-0.08B	-0.09B	-0.07B
Selling, General & Administrative (Quarter)	0.04B	0.05B	0.06B	0.05B	0.06B	0.06B	0.06B	0.07B	0.08B	0.07B	0.07B	0.07B	0.08B	-0.08B	-0.09B	-0.11B	0.12B	-0.13B	-0.16B	-0.17B
Other Operating Expenses (Quarter)			-0.26B		0.00B	0.00B		0.00B		-0.00B	0.00B	-0.00B							0.14B
Operating Expenses (Quarter)	0.14B	0.12B	-0.13B	0.15B	0.16B	0.16B	-0.10B	0.19B	0.19B	0.19B	-0.06B	0.15B	0.17B	-0.16B	-0.03B	-0.20B	0.20B	-0.21B	-0.11B	-0.24B
Rent Expense (Quarter)
Operating Income (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B
EBIT (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B
Non-operating items
Interest & Investment Income (Quarter)	0.00B	0.03B	0.02B	0.01B	0.08B	0.02B	0.00B	0.05B	0.04B	0.00B	0.04B	0.00B	0.05B	0.03B	0.09B	0.03B	0.06B	0.01B	0.21B	0.01B
Non Operating Income (Quarter)			0.02B				0.03B				0.04B				0.09B				0.21B
Non Operating Interest Expenses (Quarter)
Other Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	-0.13B	-0.18B	-0.09B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.07B	-0.03B	-0.06B
Tax Provisions (Quarter)	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.01B	-0.00B	0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	0.79B
Profit After Tax (Quarter)	0.00B	-0.00B	-0.44B	-0.14B	-0.09B	-0.17B	-0.21B	0.12B	-0.13B	-0.18B	-0.09B	0.14B	-0.12B	-0.11B	-0.04B	0.10B	0.04B	-0.07B	-0.04B	0.74B
Equity Income (Quarter)	-0.01B	-0.00B	-0.01B	0.01B	-0.00B	-0.00B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	0.03B	-0.00B	-0.01B	0.00B	-0.01B
Income from Non-Controlling Interests (Quarter)	0.00B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.21B	-0.12B	-0.00B	0.00B	-0.10B	0.00B	-0.12B	-0.11B	-0.04B	-0.10B	-0.05B	-0.00B	-0.04B	0.74B
Income from Continuing Operations (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.20B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B	-0.02B	-0.85B
Consolidated Net Income (Quarter)	-0.16B	-0.09B	-0.12B	-0.14B	-0.09B	-0.17B	-0.20B	-0.12B	-0.13B	-0.18B	-0.08B	-0.14B	-0.12B	-0.11B	-0.04B	-0.10B	-0.04B	-0.06B	-0.02B	-0.85B
Income towards Parent Company (Quarter)	0.16B	0.09B	-0.12B	0.14B	0.09B	-0.17B	-0.21B	0.12B	0.13B	0.18B	-0.10B	0.14B	0.12B	0.11B	-0.04B	-0.10B	0.05B	-0.07B	-0.04B	0.74B
Net Income towards Common Stockholders (Quarter)	0.16B	0.09B	-0.12B	0.14B	0.09B	-0.17B	-0.21B	0.12B	0.13B	0.18B	-0.10B	0.14B	0.12B	0.11B	-0.04B	-0.10B	0.05B	-0.07B	-0.04B	0.74B
Additional items
EPS (Basic) (Quarter)	3.01	1.73	-2.22	2.48	1.57	-3.09	-3.77	2.14	2.37	3.14	-1.69	2.50	2.05	1.89	-0.71	-1.66	0.75	-1.20	-0.65	12.22
EPS (Diluted) (Quarter)	3.89	2.27	-2.91	3.38	2.10	-4.14	-5.08	2.88	3.20	4.24	-2.28	3.42	1.94	1.89	-0.71	-1.66	0.71	-1.21	-0.66	11.47
Shares Outstanding (Quarter)	0.05B	0.05B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
Shares Outstanding (Diluted) (Quarter)	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.04B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
Shares Outstanding (Entity) (Quarter)	0.05B	0.05B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.27B
EBITDA (Quarter)	-0.14B	-0.11B	-0.13B	-0.14B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.15B	-0.04B	-0.05B	-0.14B	-0.11B	409.27B	-0.11B	-0.06B	0.01B	0.01B	0.03B

Research Tools

Datasets

Plans

Developers

Ascendis Pharma A Income Statement (2012-2026) | ASND

Research Tools

Datasets

Plans

Developers

Ascendis Pharma A Income Statement (2012-2026) | ASND

Create an account

Sign In

Reset Password